UNSPSC 51102800: Combination anti-infectives

This classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term ANTI-INFECTIVES. The US National Library of Medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. Typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.

UNSPSC 51102800 Combination anti-infectives, a Class code, covers the purchase of combination pharmaceutical products and anti-infective medications by state and local health systems, emergency services, and public health agencies. Recent state and local solicitations under this code reflect procurement of naloxone products paired with drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing arrangements, and medical and first aid supplies for fire-rescue operations. The scope spans finished pharmaceutical products, over-the-counter medications, emergency response consumables, and direct-to-manufacturer prescription programs designed to improve cost management and fulfillment efficiency for state agencies and local health departments.

Activity under the code emerges from state health agencies, county health departments, municipal fire services, and cooperative purchasing alliances. Recent opportunities include Seminole County, Florida (IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, response deadline July 26, 2023), the Texas Health and Human Services Commission (RFI for therapeutic pharmacy initiative direct-to-manufacturer prescription capabilities, response deadline April 3, 2026), the City of Tampa Fire Department (IFB for 169 line items of medical and first aid supplies with an estimated contract value of $700,000.00, response deadline March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount), and the Minnesota Multistate Cooperative Purchasing Alliance (RFP for generic multi-source pharmaceuticals and OTC products serving Minnesota, Oregon, and other participating jurisdictions, response deadline March 26, 2026). Geographic activity centers on Florida, Texas, and the upper Midwest, with cooperative purchasing vehicles extending scope across multiple states. Recent procurement emphasizes compliance with FDA requirements, cGMP certification, Drug Supply Chain Security Act adherence, and wholesaler integration for statewide and multi-state distribution models.